Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 4528 (MIR4528) is a small endogenous non-coding RNA molecule found in humans, belonging to the microRNA family. Like other microRNAs, MIR4528 is transcribed as a primary miRNA, processed to a precursor miRNA, and then to a ~22 nucleotide mature miRNA that becomes part of the RNA-induced silencing complex (RISC). The mature MIR4528 functions to regulate gene expression post-transcriptionally by binding to complementary sequences in target mRNAs, usually resulting in translational repression or mRNA degradation[2][4][6]. While microRNAs as a group are critical for development, cell differentiation, apoptosis, and disease, there are currently no experimentally verified data or strong predictions directly implicating MIR4528 in specific human diseases, drug responses, or as a clinical biomarker. This data reflects the general biological function and classification of MIR4528 as a microRNA, but as of now, its specific roles, therapeutic interactions, and clinical relevance remain uncharacterized in the scientific literature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA 4528 (MIR4528).